NovaBay Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript
Welcome to the 2022 special meeting of stockholders of NovaBay Pharmaceuticals. It is now 11:00 AM Pacific Time, and the meeting will please come to order. My name is Justin Hall and as CEO, General Counsel, and a Director of NovaBay, I will preside over this meeting and serve as its Chairman and Secretary.
I would now like to introduce Kathryn Wheadon of Broadridge, who will serve as the Inspector of Elections. We'll start our 2022 special meeting by conducting the official business of this meeting, which is for stockholders to consider and vote upon each of the following three proposals:
Proposal one, to approve as required and in accordance with Sections 713a and 713b of the NYSE American company guide the issuance of an aggregate of 96,468,114 shares of common stock, par value $0.01 per share, upon the exercise of the amended warrants and the new reprice warrants issued as a part of our warrant reprice transactions entered into on September 9, 2022, and upon the conversion of the series C non-voting
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
